Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
enzyme disorders
Pharma
5 years after European nod, Chiesi wins FDA approval for Lamzede
Five years after gaining approval in Europe for Lamzede, Chiesi Farmaceutici has pushed it over the finish line in the United States.
Kevin Dunleavy
Feb 17, 2023 10:09am
FDA signs off on Sanofi's rare disease drug Xenpozyme
Aug 31, 2022 3:18pm
Europe endorses two Sanofi enzyme replacement therapies
Jun 28, 2022 11:21am
Sanofi's late-onset Pompe prospect has scooped its green light
Aug 6, 2021 2:39pm
BioMarin scores long-sought FDA nod for PKU drug
May 25, 2018 11:51am
